Christopher B Granger Selected Research

Aspirin (Acetylsalicylic Acid)

11/2023	Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
11/2023	Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.
1/2022	Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
1/2022	Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.
1/2022	Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.
1/2022	Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
11/2021	Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
1/2021	Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
1/2021	Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
1/2021	Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher B Granger Research Topics

Disease

165	Atrial Fibrillation 03/2024 - 05/2006
163	Stroke (Strokes) 03/2024 - 09/2003
155	Myocardial Infarction 03/2024 - 07/2001
141	ST Elevation Myocardial Infarction 03/2024 - 08/2002
137	Hemorrhage 01/2024 - 10/2002
123	Heart Failure 03/2024 - 01/2002
83	Acute Coronary Syndrome 11/2023 - 07/2001
49	Embolism (Embolus) 01/2024 - 03/2010
37	Infarction (Infarctions) 01/2024 - 07/2002
32	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 06/2002
30	Thrombosis (Thrombus) 11/2023 - 05/2003
25	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2002
22	Hypertension (High Blood Pressure) 01/2023 - 01/2002
19	Inflammation (Inflammations) 04/2024 - 10/2005
19	Shock 05/2022 - 09/2003
16	Heart Arrest (Cardiac Arrest) 03/2024 - 10/2003
14	Out-of-Hospital Cardiac Arrest 11/2023 - 09/2014
13	Unstable Angina 01/2019 - 07/2001
12	Ischemic Stroke 03/2024 - 03/2010
12	Transient Ischemic Attack 01/2022 - 02/2010
10	Coronary Disease (Coronary Heart Disease) 01/2024 - 09/2006
10	Body Weight (Weight, Body) 01/2024 - 10/2002
10	Ischemia 12/2020 - 03/2005
9	Type 2 Diabetes Mellitus (MODY) 02/2024 - 08/2010
9	Cardiogenic Shock 03/2020 - 10/2005
8	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 01/2002
8	Embolic Stroke 01/2022 - 04/2014
8	Diabetes Mellitus 01/2018 - 02/2004
8	Thrombocytopenia (Thrombopenia) 12/2012 - 02/2005
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 02/2004
7	Hypotension (Low Blood Pressure) 11/2010 - 09/2003
6	Left Ventricular Dysfunction 03/2024 - 10/2004
6	Peripheral Arterial Disease 10/2022 - 01/2017
6	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2014
6	Sudden Death 01/2019 - 10/2004
5	Non-ST Elevated Myocardial Infarction 03/2024 - 08/2003
5	Infections 12/2023 - 09/2003
5	Chronic Renal Insufficiency 11/2023 - 11/2012

Drug/Important Bio-Agent (IBA)

96	apixabanIBA 03/2024 - 03/2010
86	Warfarin (Coumadin)FDA LinkGeneric 03/2024 - 05/2008
63	AnticoagulantsIBA 01/2024 - 11/2005
54	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2002
52	candesartanIBA 08/2021 - 09/2003
49	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 02/2002
42	pexelizumabIBA 11/2020 - 09/2003
35	Vitamin K FDA Link 01/2024 - 03/2010
27	CreatinineIBA 01/2023 - 10/2003
27	Heparin (Liquaemin)FDA LinkGeneric 12/2012 - 02/2002
20	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 04/2006
19	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 04/2006
17	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2024 - 09/2003
16	Clopidogrel (Plavix)FDA Link 01/2022 - 11/2008
15	TroponinIBA 07/2023 - 08/2002
15	Complement System Proteins (Complement)IBA 09/2013 - 09/2003
12	Glycoproteins (Glycoprotein)IBA 01/2023 - 06/2002
12	Dabigatran FDA Link 01/2022 - 11/2011
12	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 01/2002
12	Fondaparinux (Arixtra)FDA Link 12/2010 - 03/2005
12	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010 - 10/2003
11	Angiotensin Receptor AntagonistsIBA 01/2023 - 10/2004
10	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 12/2003
9	Thrombin FDA Link 11/2023 - 03/2005
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 06/2004
9	MB Form Creatine KinaseIBA 10/2014 - 04/2003
9	Factor Xa InhibitorsIBA 04/2014 - 03/2005
9	Tenecteplase FDA Link 01/2010 - 04/2003
8	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2004
8	N(4)-oleylcytosine arabinosideIBA 01/2024 - 09/2014
8	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2005
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 07/2005
7	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 03/2005
7	darapladibIBA 01/2021 - 05/2014
7	omega-Chloroacetophenone (Mace)IBA 01/2020 - 12/2017
7	AntithrombinsIBA 01/2014 - 12/2003
6	Growth Differentiation Factor 15IBA 05/2022 - 11/2014
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2019
6	Troponin T (Troponin T1)IBA 01/2022 - 01/2014
6	Mineralocorticoid Receptor AntagonistsIBA 08/2021 - 10/2004
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 05/2003
6	Eptifibatide (Integrilin)FDA Link 02/2010 - 07/2001
6	paragonIBA 10/2007 - 07/2002
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2006 - 09/2003
5	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 11/2021
5	Ramipril (Altace)FDA LinkGeneric 03/2024 - 11/2021
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2024 - 10/2018
5	RivaroxabanIBA 01/2023 - 09/2013
5	LipidsIBA 01/2023 - 11/2008
5	Cystatin CIBA 01/2022 - 11/2012

Therapy/Procedure

169	Therapeutics 02/2024 - 07/2001
132	Percutaneous Coronary Intervention 02/2024 - 08/2003
22	Thrombolytic Therapy 12/2023 - 09/2002
16	Stents 01/2021 - 12/2003
11	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2016 - 03/2005
9	Cardiopulmonary Resuscitation (CPR) 03/2024 - 09/2014
8	Resuscitation 01/2023 - 11/2014
7	Critical Care (Surgical Intensive Care) 01/2023 - 10/2009
6	Defibrillators (Defibrillator) 03/2024 - 07/2015
6	Patient Readmission 01/2021 - 11/2009
6	Length of Stay 01/2018 - 02/2004
5	Induced Hypothermia 01/2023 - 09/2016